SEP 11, 2015 9:43 PM PDT

Genomic Tools Can Save Lives

WRITTEN BY: Ilene Schneider
In a case still baffling to physicians, last summer, a 74-year-old woman from San Francisco’s Chinatown was admitted to San Francisco General Hospital and Trauma Center. Her symptoms were fever and disorientation, which rapidly degenerated into a coma.

Cutting-edge genomic tools detect brain infection.

The woman’s symptoms indicated that she was suffering from encephalitis, an infection of the brain. She was given a series of tests and drugs – for tuberculosis, bacterial and fungal infections, even Toxoplasmosis. Nothing could identify the cause of infection or do anything to revive her, and she died 16 days later.

Cases of brain infection go unsolved six times out of 10 in California, according to a 2006 UC San Francisco study that was reported in Bioscience Technology. Biochemist Joe DeRisi, PhD, and neurologist Michael Wilson, MD, of UCSF believe that they have the tools to change that statistic. When the researchers heard about last summer’s case of mystery encephalitis, they looked at cutting-edge genomic tools to determine the reason for the woman’s disease.

DeRisi, Wilson and their colleagues used rapid next-generation genomic sequencing to search the patient’s spinal fluid for non-human DNA. They then compared what they discovered against databases of genes of every known invasive microorganism or virus. By using this “metagenomic” approach, they quickly found a match: a common soil-dwelling amoeba called Balamuthia mandrillaris.

The researchers and their team have recently established a new Center for Next-Gen Precision Medicine Diagnostics to help hospitals make genome-based screens for the root causes of encephalitis part of their standard of care. They believe that the technology could save money as well as lives. During her two-week hospitalization, care for last summer’s victim cost more than $100,000. The metagenomic screen, by comparison, costs $2,000 and usually takes two days to complete.

One of the center’s first objectives will be a study to figure out when in the course of an encephalitis patient’s care the technique would have the greatest clinical importance. Researchers will go through databases of encephalitis cases to identify when inexpensive, existing treatments such as a $100 blood draw are effective at diagnosing a patient’s disease and when it might be time for clinicians to turn to the center’s big genomic tools.

UC Berkeley health economist Brent Fulton, PhD, MBA, part of the center’s team who is leading the study, said, “We all agree these metagenomic screens are happening too late. When UCSF gets the call, doctors have already tried everything under the sun and it’s a bad situation. A $2,000 test is nothing to sneeze at if it turns out to not change the usual course of care, but balanced against a multi-week, half-million dollar hospitalization, it’s nothing.”

Through the new center, DeRisi hopes to give hospitals greater access to such screening for mystery brain infections. DeRisi concluded, “We need to make this into an actual clinical diagnostic, so a doctor who doesn't know my phone number can just order up this test.”
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
FEB 28, 2021
Microbiology
Tourists Are Often Exposed to Superbacteria
FEB 28, 2021
Tourists Are Often Exposed to Superbacteria
Researchers and clinicians have long been warning about the rise of antibiotic resistant superbugs, pathogenic bacteria ...
FEB 27, 2021
Cell & Molecular Biology
It's Now Possible to Measure tRNA Levels in Cells
FEB 27, 2021
It's Now Possible to Measure tRNA Levels in Cells
There are different kinds of ribonucleic acids that play essential roles in many aspects of molecular biology, including ...
MAR 18, 2021
Genetics & Genomics
Gene Therapy Benefits Can Last Decades
MAR 18, 2021
Gene Therapy Benefits Can Last Decades
Genetic diseases arise from inborn errors in gene sequences, and researchers have long sought ways to correct those erro ...
MAR 21, 2021
Genetics & Genomics
Adding Evidence to the RNA World Hypothesis
MAR 21, 2021
Adding Evidence to the RNA World Hypothesis
Did life originate with RNA? Scientists are still trying to learn more about how the first molecules arose out of primor ...
MAR 22, 2021
Microbiology
A Cavity-Forming Germ Gets a Little Help From a Gene Cluster
MAR 22, 2021
A Cavity-Forming Germ Gets a Little Help From a Gene Cluster
There are many microbes that live in the human mouth, and while some are harmless, others like Streptococcus mutans are ...
APR 27, 2021
Genetics & Genomics
A Genetic Path Forward For Endangered Sumatran Rhinos
APR 27, 2021
A Genetic Path Forward For Endangered Sumatran Rhinos
There are fewer than 100 Sumatran rhinoceroses remaining in the world, making this animal one of the world's most endang ...
Loading Comments...